Orgad Laub

Founder and CEO at Sealantium Medical
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Israel, IL

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • Israel
    • Medical Equipment Manufacturing
    • 1 - 100 Employee
    • Founder and CEO
      • 2011 - Present

      Rosh HaAyin, Center District, Israel Sealantium Medical is developing a revolutionary surgical device, combining a polymeric degradable film with fibrin sealant to effectively manage bleeding and bodily fluid leakage during surgeries. sFilm-FS™ will be the first, innovative hemostatic and sealing patch to address the more than $1 billion surgical sealant market in almost a decade. For more information, please visit: https://sealantium-med.com

    • Israel
    • Biotechnology Research
    • 200 - 300 Employee
    • Vice President Research & Business Development.
      • 2002 - 2010

      Managed a 40-person Research and Development department that developed and registered Plasma-derived products including Immunoglobulins (IVIG) Fibrin Sealant (Quikseal) and a Fibrin Patch (Evarrest). Responsible for the development of Omrix immunoglobulin pipeline which turned into a leading business of the company (with sales of 30 MM/year)

    • Israel
    • Venture Capital and Private Equity Principals
    • 1 - 100 Employee
    • Vice President Science & Technology
      • 1995 - 2001

      Israel Chief Scientist of Yeda, responsible for the commercialization of numerous inventions generated in The Weizmann Institute of Science. Yeda was among the five most successful Technology Transfer Academic Institutions worldwide generating hundreds of million dollars in revenues.

    • Israel
    • Research
    • 700 & Above Employee
    • Associate Professor Dept. of Molecular Genetics and Virology
      • 1990 - 1995

      Published over 50 papers on the molecular biology of viruses including Hepatitis B, Polyoma, Simian Virus 40, and more.

    • Senior Scientist
      • 1990 - 1995

      Dept. of Molecular Genetics and Virology. Research subject: Regulation of Hepatitis B Gene Expression. In the frame of these studies, OL invented a novel Hepatitis B vaccine which is used to immunize babies and immunodeficient people against Hepatitis B infection.

    • Israel
    • Armed Forces
    • 700 & Above Employee
    • Army Service
      • Jan 1966 - Dec 1969

Education

  • University of California, San Francisco
    Post doctoral Fellow, School of Medicine Dept. of Biochemistry & Biophysic
    1979 - 1982
  • Weizmann Institute of Science
    Ph.D Studies (with distinction), Dept. of Genetics and Virolog
    1975 - 1979
  • Weizmann Institute of Science
    M.Sc. Studies (with Distinction), Dept. of Genetics
    1973 - 1974
  • Tel Aviv University
    B.Sc. Studies, Life Sciences

Community

You need to have a working account to view this content. Click here to join now